Publication

Enzymatically modified LDL induces cathepsin H in human monocytes: potential relevance in early atherogenesis

Journal Paper/Review - Apr 1, 2003

PubMed
Doi

Citation
Han S, Bhakdi S, Torzewski M, Hashimoto S, Paprotka K, Fenske D, Suriyaphol P, Strach K, Momeni A, Husmann M. Enzymatically modified LDL induces cathepsin H in human monocytes: potential relevance in early atherogenesis. Arterioscler Thromb Vasc Biol 2003; 23:661-7.
Type
Journal Paper/Review (English)
Journal
Arterioscler Thromb Vasc Biol 2003; 23
Publication Date
Apr 1, 2003
Issn Electronic
1524-4636
Pages
661-7
Brief description/objective

OBJECTIVE: Modification with proteases and cholesterylesterase transforms LDL to a moiety that resembles lipoproteins isolated from atherosclerotic lesions and possesses atherogenic properties. To identify changes in monocyte-derived foam cells laden with enzymatically modified LDL (E-LDL), we compared patterns of the most abundant transcripts in these cells after incubation with LDL or E-LDL. METHODS AND RESULTS: Serial analyses of gene expression (SAGE) libraries were constructed from human monocytes after treatment with LDL or E-LDL. Several tags were differentially expressed in LDL-treated versus E-LDL-treated cells, whereby marked selective induction by E-LDL of cathepsin H was conspicuous. We show that cathepsin H is expressed in atherosclerotic lesions in colocalization with E-LDL. Furthermore, we demonstrate that LDL modified with cathepsin H and cholesterylesterase can confer onto LDL the capacity to induce macrophage foam cell formation and to induce cathepsin H. CONCLUSIONS: Cathepsin H could contribute to the transformation of LDL to an atherogenic moiety; the process might involve a self-sustaining amplifying circle.